Coya Therapeutics: This BioPharma Company Has Some Big News To Share

Howard Burman, Ph.D, CEO & Chairman of Coya Therapeutics Inc COYA, was a guest on Benzinga’s All Access.

Coya is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. The company is currently developing multi-modality Treg therapies for neurodegenerative, autoimmune and metabolic diseases.

Coya has recently announced positive data from recent and ongoing trials.

Watch the full interview here:

Featured photo by Hal Gatewood on Unsplash

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.